On a quick look, the Q-2 news looks favorable to me. Does anyone here agree or disagree with the opinion that I have set forth in the subject line? I admit that I have not yet taken the time to study the MD&A, which I imagine is already on file at Sedar.
In my experience, the financial community is keen on companies that are doing something novel and that have rising revenues and that, with respect to the bottom line, are getting nearer to breakeven. I need to look again, but I am quite sure that expenses are under reasonable control at EcoSynthetix.
Good luck to all.
Robert